Affinage

PPFIBP1

Liprin-beta-1 · UniProt Q86W92

Round 2 corrected
Length
1011 aa
Mass
114.0 kDa
Annotated
2026-04-28
130 papers in source corpus 5 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PPFIBP1 (liprin-β1) is a multivalent scaffold protein that heterodimerizes with liprin-α family members through its C-terminal non-coiled-coil region and homodimerizes via its N-terminal coiled-coil domain, functioning to localize LAR-family receptor tyrosine phosphatases at specific plasma membrane sites (PMID:9624153). It is a component of cortical microtubule attachment complexes containing KANK1, liprin-α1, and LL5β, linking it to regulation of microtubule dynamics at the cell periphery (PMID:24120883). In glioma cells, PPFIBP1 promotes migration and invasion by interacting with SRCIN1 and activating FAK/Src/JNK/c-Jun signaling to upregulate MMP-2 expression, and its overexpression enhances tumor infiltration and reduces survival in xenograft models (PMID:34480020).

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 1998 High

    The founding question of how LAR-family receptor phosphatases are localized at the plasma membrane was answered by identifying PPFIBP1 (liprin-β1) as a member of the liprin family that heterodimerizes with liprin-α proteins and participates in LAR clustering, establishing the multivalent scaffold model for phosphatase localization.

    Evidence Yeast two-hybrid, co-immunoprecipitation, domain mapping, and co-expression localization studies

    PMID:9624153

    Open questions at the time
    • Whether liprin-β1 directly contacts LAR or only bridges via liprin-α remains unresolved
    • No structural data for the liprin-β1/liprin-α interface
    • Functional consequence of liprin-β1 loss on LAR signaling was not tested
  2. 2011 Medium

    Placing PPFIBP1 within cortical microtubule attachment complexes containing KANK1, liprin-α1, and LL5β expanded its functional context from phosphatase scaffolding to regulation of microtubule capture at the cell periphery, while proteomic detection in focal adhesions linked it to the mechanosensitive adhesion compartment.

    Evidence Affinity proteomics, co-immunoprecipitation, confocal microscopy, and quantitative focal adhesion proteomics

    PMID:21423176 PMID:24120883

    Open questions at the time
    • The specific functional contribution of PPFIBP1 to cortical microtubule attachment was not individually dissected
    • Focal adhesion detection was proteomics-based without direct functional follow-up for PPFIBP1
    • Whether PPFIBP1's role in cortical complexes is independent of its LAR-scaffolding function is unknown
  3. 2011 High

    Identification of the PPFIBP1-ALK fusion in inflammatory myofibroblastic tumor demonstrated that the PPFIBP1 locus can serve as an oncogenic fusion partner, with the chimeric protein showing transforming activity both in vitro and in vivo.

    Evidence 5'-RACE, RT-PCR, FISH confirmation, NIH 3T3 focus formation assay, and in vivo tumorigenicity assay

    PMID:21430068

    Open questions at the time
    • Whether the coiled-coil domain of PPFIBP1 drives constitutive dimerization of the fusion kinase was not tested
    • Prevalence of this fusion across tumor types beyond IMT is not established in this study
  4. 2021 High

    The mechanism by which PPFIBP1 promotes cancer cell invasion was resolved: interaction with SRCIN1 activates FAK/Src/JNK/c-Jun signaling, upregulating MMP-2 and driving glioma cell migration, invasion, and in vivo tumor infiltration.

    Evidence Knockdown/overexpression, transwell and scratch assays, co-immunoprecipitation with SRCIN1, pharmacological pathway inhibition, and xenograft models in glioma cells

    PMID:34480020

    Open questions at the time
    • Whether the SRCIN1–FAK/Src axis operates in non-glioma contexts is untested
    • The structural basis of the PPFIBP1–SRCIN1 interaction is unknown
    • Relationship between the LAR-scaffolding and SRCIN1-mediated invasion functions has not been explored

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PPFIBP1's distinct interaction networks—LAR phosphatase scaffolding, cortical microtubule attachment, and SRCIN1-mediated invasion signaling—are coordinated or segregated in different cellular contexts remains an open question.
  • No structure of PPFIBP1 or its complexes is available
  • Whether liprin-β1 has catalytic or enzymatic activity independent of scaffolding is unknown
  • Tissue-specific functions and knockout phenotypes in mammalian models are poorly characterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3
Localization
GO:0005886 plasma membrane 2
Pathway
R-HSA-162582 Signal Transduction 1
Complex memberships
KANK1–liprin–LL5β cortical complexLiprin-α/β complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1998 PPFIBP1 (liprin-β1) was identified as a member of the liprin family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. The C-terminal non-coiled-coil region of alpha-liprins binds to the membrane-distal phosphatase domains of LAR family members, and alpha-liprins also bind to the C-terminal non-coiled-coil region of beta-liprins (including PPFIBP1). Both alpha- and beta-liprins homodimerize via their N-terminal coiled-coil regions, establishing that liprins are multivalent proteins. Co-expression studies showed that liprin-alpha2 alters LAR cellular localization and induces LAR clustering, implicating liprins in localizing LAR family phosphatases at specific plasma membrane sites. Yeast two-hybrid, co-immunoprecipitation, co-expression localization studies, domain mapping The Journal of biological chemistry High 9624153
2011 PPFIBP1 (liprin-β1) was identified as a component of cortical microtubule attachment complexes. KIF21A is recruited to the cell cortex by KANK1, which co-clusters with liprin-α1/β1 and components of LL5β-containing complexes, placing liprin-β1 (PPFIBP1) within a multi-protein cortical complex that regulates microtubule growth at the cell periphery. Affinity proteomics, co-immunoprecipitation, confocal microscopy, functional rescue assays Developmental cell Medium 24120883
2011 PPFIBP1 was identified as part of the myosin-II-responsive focal adhesion proteome; its abundance in focal adhesions changes with myosin II activity, placing it within the contractility-regulated focal adhesion compartment. Quantitative proteomic analysis of isolated focal adhesions with and without myosin II inhibition (blebbistatin), mass spectrometry Nature cell biology Low 21423176
2011 PPFIBP1 was identified as a novel ALK fusion partner (PPFIBP1-ALK) in pulmonary inflammatory myofibroblastic tumor (IMT). The PPFIBP1-ALK fusion was confirmed by 5'-RACE, RT-PCR, genomic PCR, and FISH. The fusion protein demonstrated transforming activity in NIH 3T3 fibroblasts in a focus formation assay and in an in vivo tumorigenicity assay using a recombinant retrovirus, establishing that PPFIBP1-ALK is an oncogenic fusion kinase. 5'-RACE, RT-PCR, genomic PCR, FISH, focus formation assay, in vivo tumorigenicity assay in NIH 3T3 fibroblasts Clinical cancer research : an official journal of the American Association for Cancer Research High 21430068
2021 PPFIBP1 promotes glioma cell migration and invasion through activation of the FAK/Src/JNK signaling pathway. Overexpression of PPFIBP1 activated FAK, Src, JNK, and c-Jun, enhancing MMP-2 expression, while knockdown inhibited invasion and migration in scratch and transwell assays. The mechanism involves interaction with SRCIN1 (p140Cap). Pharmacological inhibition of FAK and Src phosphorylation reversed the pro-invasive effects of PPFIBP1 overexpression. In xenograft models, PPFIBP1 overexpression facilitated tumor infiltration and reduced survival. Scratch assay, transwell invasion assay, RNA-seq, GO enrichment, Western blotting for pathway activation, pharmacological inhibition, xenograft mouse model, co-immunoprecipitation with SRCIN1 Cell death & disease High 34480020

Source papers

Stage 0 corpus · 130 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2861 17081983
2001 PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature immunology 2344 11224527
2012 Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 1718 22658674
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2017 Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cell reports 1448 28494868
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2020 A reference map of the human binary protein interactome. Nature 849 32296183
2018 VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation. Cell discovery 829 29507755
2007 Large-scale mapping of human protein-protein interactions by mass spectrometry. Molecular systems biology 733 17353931
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
2016 PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 644 27069084
2020 Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science (New York, N.Y.) 564 33060197
2003 PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proceedings of the National Academy of Sciences of the United States of America 518 12697896
2017 PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 491 28619999
2011 Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nature cell biology 490 21423176
2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome research 438 15489334
2015 A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface. Cell 433 26638075
2022 OpenCell: Endogenous tagging for the cartography of human cellular organization. Science (New York, N.Y.) 432 35271311
2004 Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Current biology : CB 386 15324660
2013 Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Science signaling 383 24255178
2021 A proximity-dependent biotinylation map of a human cell. Nature 339 34079125
2008 Arrangement of L2 within the papillomavirus capsid. Journal of virology 271 18367526
2014 RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. The Journal of experimental medicine 269 24752301
1998 Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. The Journal of biological chemistry 246 9624153
2016 An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. Nature communications 211 27173435
2018 An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations. Nature communications 201 29568061
2004 Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. The Journal of biological chemistry 185 15161933
2013 L2, the minor capsid protein of papillomavirus. Virology 179 23689062
2020 Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nature communications 167 32572027
2014 E-cadherin interactome complexity and robustness resolved by quantitative proteomics. Science signaling 162 25468996
2007 E1-L2 activates both ubiquitin and FAT10. Molecular cell 161 17889673
2019 A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nature immunology 159 30833792
2023 Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. Nature 153 37138075
2005 Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Molecular & cellular proteomics : MCP 153 15778465
2013 CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor. Developmental cell 152 24120883
2003 Adenosine kinase is inactivated by geminivirus AL2 and L2 proteins. The Plant cell 148 14615595
2009 Ubiquitin-mediated proteolysis of HuR by heat shock. The EMBO journal 142 19322201
2019 Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms. Nature cell biology 137 31871319
2015 Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma. Cancer immunology research 121 26081225
2003 Interactions between papillomavirus L1 and L2 capsid proteins. Journal of virology 109 12663788
2010 Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 104 20722638
2008 Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. The Journal of biological chemistry 102 18216018
1997 Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 96 9210666
2021 CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer. Journal of hematology & oncology 95 33849617
1992 Macrophages in Drosophila embryos and L2 cells exhibit scavenger receptor-mediated endocytosis. Proceedings of the National Academy of Sciences of the United States of America 88 1438223
2021 The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation. Acta pharmaceutica Sinica. B 86 35530130
2003 Cell surface-binding motifs of L2 that facilitate papillomavirus infection. Journal of virology 82 12610128
2024 The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer 81 38267628
2002 Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein. Journal of virology 81 12208958
2022 Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy. British journal of cancer 80 36522474
2011 Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clinical cancer research : an official journal of the American Association for Cancer Research 78 21430068
2019 Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity. Clinical cancer research : an official journal of the American Association for Cancer Research 77 31076547
2021 PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. Journal for immunotherapy of cancer 76 34697216
2010 Crystal structure of Get4-Get5 complex and its interactions with Sgt2, Get3, and Ydj1. The Journal of biological chemistry 76 20106980
2004 Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. Journal of virology 71 15140951
2019 The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals. The Journal of biological chemistry 70 31882544
2019 TBK1-mediated phosphorylation of LC3C and GABARAP-L2 controls autophagosome shedding by ATG4 protease. EMBO reports 69 31709703
2014 Synthesis of L-2,3-diaminopropionic acid, a siderophore and antibiotic precursor. Chemistry & biology 65 24485762
2014 PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment. Journal of neuro-oncology 65 25349132
2015 A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking. Journal of virology 64 26202251
1994 Chlamydia trachomatis serovar L2 induces protein tyrosine phosphorylation during uptake by HeLa cells. Infection and immunity 62 7523300
2009 AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 61 19414581
2016 Developments in L2-based human papillomavirus (HPV) vaccines. Virus research 60 27889616
2012 Structures of the Sgt2/SGTA dimerization domain with the Get5/UBL4A UBL domain reveal an interaction that forms a conserved dynamic interface. Cell reports 56 23142665
1998 DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology 55 9568045
2022 Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL. Journal for immunotherapy of cancer 52 35365585
2015 A complex of Rab13 with MICAL-L2 and α-actinin-4 is essential for insulin-dependent GLUT4 exocytosis. Molecular biology of the cell 52 26538022
2017 Subcellular Trafficking of the Papillomavirus Genome during Initial Infection: The Remarkable Abilities of Minor Capsid Protein L2. Viruses 51 29207511
2021 Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 50 34011561
1997 Isolation of a cDNA encoding Fasciola hepatica cathepsin L2 and functional expression in Saccharomyces cerevisiae. Molecular and biochemical parasitology 50 9274877
2017 Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. Cancer immunology research 49 29038297
2012 Regulation of chaperone effects on a yeast prion by cochaperone Sgt2. Molecular and cellular biology 49 23045389
2019 Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today? Viruses 48 31877975
2006 Roles of the human Rad51 L1 and L2 loops in DNA binding. The FEBS journal 48 16780572
2010 LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity. American journal of physiology. Endocrinology and metabolism 47 20407010
2010 Ribosomal protein L2 associates with E. coli HtpG and activates its ATPase activity. Biochemical and biophysical research communications 47 20727857
2002 Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia. The Journal of antimicrobial chemotherapy 47 11815585
2012 PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production. Mucosal immunology 43 23149662
2000 Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 43 11040122
2015 Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition. Cancer letters 42 25864591
2014 Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types. PloS one 42 24816794
2018 Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma. Oncoimmunology 41 30546952
2007 Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus research 41 17869365
2024 A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. Nature chemical biology 40 39103634
2016 The Tick Protein Sialostatin L2 Binds to Annexin A2 and Inhibits NLRC4-Mediated Inflammasome Activation. Infection and immunity 40 27045038
2016 Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins. Journal of virology 40 27122588
1995 Histidine 229 in protein L2 is apparently essential for 50S peptidyl transferase activity. Biochemistry and cell biology = Biochimie et biologie cellulaire 40 8722025
2021 RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates. Journal of clinical medicine 39 33802456
2020 Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 39 32367440
2021 PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway. Cell death & disease 38 34480020
2002 Identification of a peptide mimic of the L2/HNK-1 carbohydrate epitope. Journal of neurochemistry 38 12472892
2007 Expression, processing, and localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental cycle. PloS one 37 17593967
2021 FasL+ PD-L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 36 34957697
2009 Insights into the role and function of L2, the minor capsid protein of papillomaviruses. Archives of virology 36 19169853
2018 Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses. Journal of virology 34 29212932
2019 MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration. Journal of cellular and molecular medicine 33 31034158
1988 Gene dosage alteration of L2 ribosomal protein genes in Saccharomyces cerevisiae: effects on ribosome synthesis. Molecular and cellular biology 33 3062369
2015 Tick sialostatins L and L2 differentially influence dendritic cell responses to Borrelia spirochetes. Parasites & vectors 32 25975355
1988 The binding site for ribosomal protein L2 within 23S ribosomal RNA of Escherichia coli. The EMBO journal 32 3061801
2014 Cxcl8-l1 and Cxcl8-l2 are required in the zebrafish defense against Salmonella Typhimurium. Developmental and comparative immunology 31 25445910
2007 Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering. Oncogene 31 17891173
2019 Structural and biochemical characterization of 20β-hydroxysteroid dehydrogenase from Bifidobacterium adolescentis strain L2-32. The Journal of biological chemistry 30 31209107
2010 AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 30 20385866
2002 Cytotoxicity of ingredients of various dental materials and related compounds in L2- and A549 cells. Journal of biomedical materials research 30 12209911
2011 Cooperative and independent activities of Sgt2 and Get5 in the targeting of tail-anchored proteins. Biological chemistry 29 21619481
2014 Analysis of geminivirus AL2 and L2 proteins reveals a novel AL2 silencing suppressor activity. Journal of virology 28 25552721
2013 Structure of the Sgt2/Get5 complex provides insights into GET-mediated targeting of tail-anchored membrane proteins. Proceedings of the National Academy of Sciences of the United States of America 28 23297211
1995 Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein. Virology 28 7491757
2021 Retromer stabilizes transient membrane insertion of L2 capsid protein during retrograde entry of human papillomavirus. Science advances 26 34193420
2020 Optimization production of exopolysaccharide from Leuconostoc lactis L2 and its partial characterization. International journal of biological macromolecules 26 32439434
2016 PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer. American journal of clinical and experimental urology 26 27069956
2013 TLR2 directing PD-L2 expression inhibit T cells response in Schistosoma japonicum infection. PloS one 25 24376539
2011 Two forms of ribosomal protein L2 of Escherichia coli that inhibit DnaA in DNA replication. Nucleic acids research 25 21288885
2021 Ribosome-bound Get4/5 facilitates the capture of tail-anchored proteins by Sgt2 in yeast. Nature communications 24 33542241
2020 Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases. Vaccines 24 33019516
2018 Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism. Frontiers in immunology 23 30559738
2013 Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PloS one 23 23372836
2021 PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment. Communications biology 22 33990697
2018 Clinicopathological analysis of PD-L2 expression in colorectal cancer. OncoTargets and therapy 22 30464512
2022 Diacylglycerols interact with the L2 lipidation site in TRPC3 to induce a sensitized channel state. EMBO reports 21 35604352
2020 GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors. Scientific reports 21 32493985
2016 Progress and prospects for L2-based human papillomavirus vaccines. Expert review of vaccines 21 26901354
2015 Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies. Clinical and vaccine immunology : CVI 21 25972404
2009 Immunogenicity of an HPV-16 L2 DNA vaccine. Vaccine 21 19559114
2021 Molecular basis of tail-anchored integral membrane protein recognition by the cochaperone Sgt2. The Journal of biological chemistry 20 33610544
2021 Comprehensive characterization of tissue-specific chromatin accessibility in L2 Caenorhabditis elegans nematodes. Genome research 20 33888511
2009 Role of L2 cysteines in papillomavirus infection and neutralization. Virology journal 20 19860897